Urethral bulking with Bulkamid: An analysis of efficacy, safety profile, and predictors of functional outcomes in a single‐center cohort

2020 ◽  
Vol 39 (5) ◽  
pp. 1523-1528
Author(s):  
Alessandro Giammò ◽  
Paolo Geretto ◽  
Enrico Ammirati ◽  
Alberto Manassero ◽  
Luisella Squintone ◽  
...  
2021 ◽  
Author(s):  
Motohiro Fujiwara ◽  
Takeshi Yuasa ◽  
Tetsuya Urasaki ◽  
Yoshinobu Komai ◽  
Ryo Fujiwara ◽  
...  

2014 ◽  
Vol 42 (2) ◽  
pp. 193-195 ◽  
Author(s):  
Rossella Reggia ◽  
Franco Franceschini ◽  
Angela Tincani ◽  
Ilaria Cavazzana

Objective.Subcutaneous (SC) abatacept (ABA) is comparable to intravenous (IV) formulation in terms of efficacy and safety profile. Our work analyzed the switch to SC formulation from IV administration in patients with rheumatoid arthritis.Methods.Fifty-one patients treated with SC ABA were included. Clinical data were obtained from clinical charts.Results.Fourteen patients relapsed and needed to return to the IV administration. Neither clinical and laboratory features nor the previous therapies were identified as risk factors for SC formulation inefficacy. Disease activity decreased after the return to IV infusions.Conclusion.SC ABA showed a risk of relapse in 27% of cases. The reinsertion of the IV administration quickly reinstated disease control.


2020 ◽  
Vol 19 ◽  
pp. e2326
Author(s):  
M.C. Ferriero ◽  
R. Mastroianni ◽  
M. Costantini ◽  
G. Tuderti ◽  
U. Anceschi ◽  
...  

2017 ◽  
Vol 47 ◽  
pp. S20
Author(s):  
P.P. Bletsis ◽  
A. Bucknor ◽  
A. Chatta ◽  
P. Kamali ◽  
R. Flecha-Hirsch ◽  
...  

2020 ◽  
Vol 46 (3) ◽  
pp. 341-350 ◽  
Author(s):  
Ibrahim Kartal ◽  
Nihat Karakoyunlu ◽  
Çağlar Çakici ◽  
Osman Karabacak ◽  
Levent Sağnak ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document